February 25, 2011
A drugmaker, a dermatology lab and New York University slapped Novartis AG unit Sandoz Inc. with a patent infringement suit Wednesday in Delaware over Sandoz's bid for regulatory approval to market a generic version of the rosacea treatment Oracea.